Concord Biotech P/B Ratio
Concord Biotech (CONCORDBIO) P/B ratio is 7.02 (High), book value per share ₹1833.64 vs Healthcare average P/B of -0.34 — Very High - Significant premium, high growth expectations or speculative. Compare with CONCORDBIO fair value estimate to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
CONCORDBIO P/B Ratio — Valuation Insights & Book Value Analysis
Concord Biotech price-to-book ratio interpretation, valuation status and historical context — current P/B 7.02 (High). View CONCORDBIO annual price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 7.02, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 538.2% above historical average
- Trading at premium to sector average PB of -0.34
Concord Biotech P/B Ratio Historical Trend
CONCORDBIO annual price-to-book ratio — 4 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Concord Biotech share price today.
CONCORDBIO Historical P/B Ratio — Book Value Per Share & Year-End Price
Concord Biotech annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.73 | ₹1833.64 | ₹1337.60 | ₹2,017 | Low |
| 2025 | 0.82 | ₹1648.18 | ₹1345.60 | ₹1,813 | Low |
| 2024 | 1.59 | ₹1388.18 | ₹2210.75 | ₹1,527 | Moderate |
| 2023 | 1.26 | ₹1172.73 | ₹1471.80 | ₹1,290 | Moderate |
CONCORDBIO vs Healthcare Peers — P/B Ratio Comparison
Concord Biotech P/B 7.02 vs Healthcare average -0.34, median 0.61 — range -18.41–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Parmax Pharma | PARMAX | -3.24 | ₹23 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.57 | ₹49 | Low |